General MedicationsOPHTHALMICGeneric
MEMBRANEBLUE
TRYPAN BLUE
Standard Dose
0.15%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MEMBRANEBLUE is listed in Drugs@FDA under application 022278 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient TRYPAN BLUE Form and strength SOLUTION;OPHTHALMIC - 0.15% Sponsor DORC Submission history Latest submission status date: 2025-11-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview MEMBRANEBLUE is listed in Drugs@FDA under application 022278 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient TRYPAN BLUE Form and strength SOLUTION;OPHTHALMIC - 0.15% Sponsor DORC Submission history Latest submission status date: 2025-11-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.